Clinical efficacy and mechanistic evaluation of aflibercept for proliferative diabetic retinopathy (acronym CLARITY): a multicentre phase IIb randomised active-controlled clinical...

por Sivaprasad, Sobha, Prevost, A Toby, Bainbridge, James, Edwards, Rhiannon Tudor, Hopkins, David, Kelly, Joanna, Luthert, Phil, Murphy, Caroline, Ramu, Jayashree, Sarafraz-Shekary, Negin, Vasconcelos, Joana, White-Alao, Beverley, Hykin, Philip
Publicado 2015

Second-line agents in myositis: 1-year factorial trial of additional immunosuppression in patients who have partially responded to steroids

por Ibrahim, Fowzia, Choy, Ernest, Gordon, Patrick, Doré, Caroline J., Hakim, Alan, Kitas, George, Isenberg, David, Griffiths, Bridget, Lecky, Bryan, Chakravarty, Kuntal, Winer, John, Danko, Katalin, Cooper, Robert G., White-Alao, Beverley, Scott, David L.
Publicado 2015